Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT02675218
Eligibility Criteria:
Inclusion Criteria:
* Signed and dated informed consent form,
* Age ≥ 18 years,
* Rheumatoid arthritis diagnosis according to ACR/EULAR 2010 criteria
* Abatacept therapy sub-cutaneous required according EULAR recommendations
* Patients affiliated to health insurance
Exclusion Criteria:
* Other arthritis than rheumatoid arthritis,
* Contraindication to abatacept,
* Concomitant treatment with zoledronic acid (Aclasta®) or denosumab (Prolia®),
* Injection intravenously or intra-articular at the 2nd and 3rd metacarpophalangeal joint of the dominant hand during the 3 months prior to inclusion,
* Prior or planned joint surgery at the 2nd or 3rd metacarpophalangeal joint of the dominant hand over the one year study,
* No recent used of high density contrast material,
* Pregnancy or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02675218
Study Brief:
Protocol Section:
NCT02675218